These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3301783)

  • 1. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid.
    De Mol P; Mets T; Lagasse R; Vandepitte J; Mutwewingabo A; Butzler JP
    J Antimicrob Chemother; 1987 May; 19(5):695-8. PubMed ID: 3301783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nalidixic-acid-resistant Shigella dysenteriae I.
    Panhotra BR; Desai B; Sharma PL
    Lancet; 1985 Mar; 1(8431):763. PubMed ID: 2858035
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.
    Rogerie F; Ott D; Vandepitte J; Verbist L; Lemmens P; Habiyaremye I
    Antimicrob Agents Chemother; 1986 May; 29(5):883-6. PubMed ID: 3524434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nalidixic acid in Shigella dysenteriae outbreaks.
    Malengreau M
    Lancet; 1984 Jul; 2(8395):172. PubMed ID: 6146074
    [No Abstract]   [Full Text] [Related]  

  • 5. Changing antibiotic sensitivity patterns in shigellosis.
    Lamabadusuriya SP; Devasiri IV; Jayantha UK; Perera C
    Ceylon Med J; 1991 Dec; 36(4):159-61. PubMed ID: 1807844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing incidence of antibiotic resistance in shigellas from humans in England and Wales: recommendations for therapy.
    Cheasty T; Skinner JA; Rowe B; Threlfall EJ
    Microb Drug Resist; 1998; 4(1):57-60. PubMed ID: 9533726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance of Shigellae isolated in Michigan.
    Gordon RC; Thompson TR; Carlson W; Dyke JW; Stevens LI
    JAMA; 1975 Mar; 231(11):1159-61. PubMed ID: 1089819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The adaptation of therapeutic standards as a function of antibiotic sensitivity of strains of Shigella spp. isolated in Rwanda in 1997].
    Aldighieri S; Kamoso P; Suermondt G; Rugimbanya P; Ngabonziza C; Kayirangwa E
    Med Trop (Mars); 1997; 57(4):412. PubMed ID: 9612786
    [No Abstract]   [Full Text] [Related]  

  • 9. Outbreak of dysentery due to nalidixic acid resistant S. dysenteriae 1 at Agartala, Tripura: a hospital based study.
    Datta P; Sen D
    Indian J Public Health; 1990; 34(1):11-4. PubMed ID: 2101382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid.
    Vinh H; Wain J; Chinh MT; Tam CT; Trang PT; Nga D; Echeverria P; Diep TS; White NJ; Parry CM
    Trans R Soc Trop Med Hyg; 2000; 94(3):323-6. PubMed ID: 10975012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple drug-resistant Shigella dysenteriae type 1 in Rajbari district, Bangladesh.
    Jahan Y; Hossain A
    J Diarrhoeal Dis Res; 1997 Mar; 15(1):17-20. PubMed ID: 9308296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [TREATMENT OF BACILLARY DYSEMTERY WITH NALIDIXIC ACID].
    NAKAMIZO Y; TAKAHASHI R; TANAKA E
    Nihon Densenbyo Gakkai Zasshi; 1963 Oct; 37():241-7. PubMed ID: 14092815
    [No Abstract]   [Full Text] [Related]  

  • 13. Nalidixic acid-resistant Shigella dysenteriae type I in KwaZulu-Natal.
    Karas JA; Pillay DG
    S Afr Med J; 1996 Jan; 86(1):93. PubMed ID: 8685796
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiresistant Shigella infections in Bangladesh.
    Bennish M; Eusof A; Kay B; Wierzba T
    Lancet; 1985 Aug; 2(8452):441. PubMed ID: 2863461
    [No Abstract]   [Full Text] [Related]  

  • 15. Increase in multiresistance of Shigella dysenteriae type 1 strain in Rwanda.
    Mutwewingabo A; Mets T
    East Afr Med J; 1987 Dec; 64(12):812-5. PubMed ID: 3333152
    [No Abstract]   [Full Text] [Related]  

  • 16. Emergence of nalidixic acid resistant Shigella dysenteriae type 1 in Thailand: an outbreak associated with consumption of a coconut milk dessert.
    Hoge CW; Bodhidatta L; Tungtaem C; Echeverria P
    Int J Epidemiol; 1995 Dec; 24(6):1228-32. PubMed ID: 8824867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiological investigation of diarrhoea epidemics among Rwandan refugees in Zaire.
    Islam MS; Siddique AK; Salam A; Akram K; Majumdar RN; Zaman K; Fronczak N; Laston S
    Trans R Soc Trop Med Hyg; 1995; 89(5):506. PubMed ID: 8560524
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic effectiveness of nevigramon in the complex treatment of acute dysentery].
    Gebesh VV; Koval'chuk VK; Ianushevskaia RI; Sofienko NIa; Lysak LI
    Vrach Delo; 1980 May; (5):110-3. PubMed ID: 6994350
    [No Abstract]   [Full Text] [Related]  

  • 19. Shigellosis (antibiotic resistance and transfer of R-factor).
    Gaikwad S; Deodhar LP
    J Postgrad Med; 1985 Jan; 31(1):24-7. PubMed ID: 3900357
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial susceptibility of Shigella flexneri and S. dysenteriae isolated from stool specimens of patients with bloody diarrhoea in Mwanza, Tanzania.
    Temu MM; Kaatano GM; Miyaye ND; Buhalata SN; Shushu ML; Kishamawe C; Changalucha JM
    Tanzan Health Res Bull; 2007 Sep; 9(3):186-9. PubMed ID: 18087897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.